Coreceptor Use in Nonhuman Primate Models of HIV Infection

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2011 Feb 3

PMID 21284906

Citations 13

Authors

Silvana Tasca Sina

Wuze Ren

Cecilia Cheng-Mayer

Affiliations

Soon will be listed here.

Abstract

SIV or SHIV infection of nonhuman primates (NHP) has been used to investigate the impact of coreceptor usage on the composition and dynamics of the CD4+ T cell compartment, mechanisms of disease induction and development of clinical syndrome. As the entire course of infection can be followed, with frequent access to tissue compartments, infection of rhesus macaques with CCR5-tropic SHIVs further allows for study of HIV-1 coreceptor switch after intravenous and mucosal inoculation, with longitudinal and systemic analysis to determine the timing, anatomical sites and cause for the change in envelope glycoprotein and coreceptor preference. Here, we review our current understanding of coreceptor use in NHPs and their impact on the pathobiological characteristics of the infection, and discuss recent advances in NHP studies to uncover the underlying selective pressures for the change in coreceptor preference in vivo.

Citing Articles

In vivo evolution of env in SHIV-AD8-infected rhesus macaques after AAV-vectored delivery of eCD4-Ig.

OHagan D, Shandilya S, Hopkins L, Hahn P, Fuchs S, Martinez-Navio J Mol Ther. 2024; 33(2):560-579.

PMID: 39673132 PMC: 11853013. DOI: 10.1016/j.ymthe.2024.12.015.

Allogeneic MHC-matched T-cell receptor α/β-depleted bone marrow transplants in SHIV-infected, ART-suppressed Mauritian cynomolgus macaques.

Weinfurter J, DSouza S, Matschke L, Bennett S, Kelnhofer-Millevolte L, Suknuntha K Sci Rep. 2022; 12(1):12345.

PMID: 35853970 PMC: 9296477. DOI: 10.1038/s41598-022-16306-z.

Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies.

Chen M, Li M, Budai M, Rice A, Kimata J, Mohan M J Leukoc Biol. 2022; 112(5):1245-1259.

PMID: 35362118 PMC: 9522917. DOI: 10.1002/JLB.4MR0222-606.

SNP-based genetic characterization of the Tulane National Primate Research Center's conventional and specific pathogen-free rhesus macaque (Macaca mulatta) populations.

Kanthaswamy S, Ng J, Oldt R, Phillippi-Falkenstein K, Kubisch H J Med Primatol. 2017; 47(1):29-34.

PMID: 28639374 PMC: 5740026. DOI: 10.1111/jmp.12284.

HIV-1-induced AIDS in monkeys.

Hatziioannou T, Del Prete G, Keele B, Estes J, McNatt M, Bitzegeio J Science. 2014; 344(6190):1401-5.

PMID: 24948736 PMC: 4266393. DOI: 10.1126/science.1250761.

References

Hirsch V, Lifson J . Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv Pharmacol. 2000; 49:437-77. DOI: 10.1016/s1054-3589(00)49034-4. View

Zhang Y, Lou B, Lal R, Gettie A, Marx P, Moore J . Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J Virol. 2000; 74(15):6893-910. PMC: 112207. DOI: 10.1128/jvi.74.15.6893-6910.2000. View

Beer B, Brown C, Whitted S, Goldstein S, Goeken R, Plishka R . Immunodeficiency in the absence of high viral load in pig-tailed macaques infected with Simian immunodeficiency virus SIVsun or SIVlhoest. J Virol. 2005; 79(22):14044-56. PMC: 1280237. DOI: 10.1128/JVI.79.22.14044-14056.2005. View

Bogers W, Cheng-Mayer C, Montelaro R . Developments in preclinical AIDS vaccine efficacy models. AIDS. 2000; 14 Suppl 3:S141-51. View

Ling B, Apetrei C, Pandrea I, Veazey R, Lackner A, Gormus B . Classic AIDS in a sooty mangabey after an 18-year natural infection. J Virol. 2004; 78(16):8902-8. PMC: 479084. DOI: 10.1128/JVI.78.16.8902-8908.2004. View

Hirsch V, Santra S, Goldstein S, Plishka R, Buckler-White A, Seth A . Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques. J Virol. 2003; 78(1):275-84. PMC: 303408. DOI: 10.1128/jvi.78.1.275-284.2004. View

Keele B, Jones J, Terio K, Estes J, Rudicell R, Wilson M . Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature. 2009; 460(7254):515-9. PMC: 2872475. DOI: 10.1038/nature08200. View

Michael N, Nelson J, Kewalramani V, Chang G, OBrien S, Mascola J . Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol. 1998; 72(7):6040-7. PMC: 110409. DOI: 10.1128/JVI.72.7.6040-6047.1998. View

van t Wout A, Blaak H, Ran L, Brouwer M, Kuiken C, Schuitemaker H . Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection. J Virol. 1998; 72(6):5099-107. PMC: 110075. DOI: 10.1128/JVI.72.6.5099-5107.1998. View

10.

Sheehy A, Gaddis N, Choi J, Malim M . Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002; 418(6898):646-50. DOI: 10.1038/nature00939. View

11.

Pandrea I, Kornfeld C, Ploquin M, Apetrei C, Faye A, Rouquet P . Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol. 2005; 79(10):6249-59. PMC: 1091729. DOI: 10.1128/JVI.79.10.6249-6259.2005. View

12.

Regoes R, Bonhoeffer S . The HIV coreceptor switch: a population dynamical perspective. Trends Microbiol. 2005; 13(6):269-77. DOI: 10.1016/j.tim.2005.04.005. View

13.

Picker L, Hagen S, Lum R, Reed-Inderbitzin E, Daly L, Sylwester A . Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J Exp Med. 2004; 200(10):1299-314. PMC: 2211921. DOI: 10.1084/jem.20041049. View

14.

Bunnik E, Quakkelaar E, van Nuenen A, Boeser-Nunnink B, Schuitemaker H . Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient. J Virol. 2006; 81(2):525-31. PMC: 1797458. DOI: 10.1128/JVI.01983-06. View

15.

Alkhatib G, Combadiere C, Broder C, Feng Y, Kennedy P, Murphy P . CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996; 272(5270):1955-8. DOI: 10.1126/science.272.5270.1955. View

16.

Ince W, Zhang L, Jiang Q, Arrildt K, Su L, Swanstrom R . Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model. J Virol. 2010; 84(6):2740-52. PMC: 2826074. DOI: 10.1128/JVI.02180-09. View

17.

Kuwata T, Shioda T, Igarashi T, Ido E, Ibuki K, Enose Y . Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1. AIDS. 1996; 10(12):1331-7. DOI: 10.1097/00002030-199610000-00004. View

18.

Tso F, Hoffmann F, Tully D, Lemey P, Rasmussen R, Zhang H . A comparative study of HIV-1 clade C env evolution in a Zambian infant with an infected rhesus macaque during disease progression. AIDS. 2009; 23(14):1817-28. PMC: 2901162. DOI: 10.1097/QAD.0b013e32832f3da6. View

19.

Reimann K, Parker R, Seaman M, Beaudry K, Beddall M, Peterson L . Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J Virol. 2005; 79(14):8878-85. PMC: 1168747. DOI: 10.1128/JVI.79.14.8878-8885.2005. View

20.

ONeil S, Novembre F, Hill A, Suwyn C, Hart C, Anderson D . Progressive infection in a subset of HIV-1-positive chimpanzees. J Infect Dis. 2000; 182(4):1051-62. DOI: 10.1086/315823. View